A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
Clinical trial NCT04592341 · TERMINATED
Trial details
- NCT number
- NCT04592341
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2023-01-11
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.